Ayalon Insurance Company (AYAL) Fair Value & Analysis
Financial Services · Il · Market cap 4.6B ILA
Analysis
Ayalon Insurance Company (AYAL) currently trades at 131.00 ILA, while our model-based Fair Value estimate is 202.30 ILA — implying the stock looks roughly 54.4% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Ayalon Insurance Company Ltd, through its subsidiaries, provides various insurance products in Israel. It offers life insurance and long-term savings plans, such as pension savings insurance funds and savings policies; and general insurance cover products, including property, liability, marine, and third-party liability insurance, as well as medical expense, motor property insurance, property and third-party motor insurance, and property auto insurance. The company also provides health insurance products, including critical illness, nursing care, dental, personal accident, and medical insurance for foreign workers, and employer's, third-party, professional, directors and officers, and product liability insurance. In addition, it offers fire, engineering, and contractor works insurance; contractors' insurance; comprehensive insurance for businesses and offices; mechanical engineering equipment insurance; personal accident; mechanical breakdown, electronic equipment, and agricultural …
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.